1. Home
  2. EXAS vs CGNX Comparison

EXAS vs CGNX Comparison

Compare EXAS & CGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$101.91

Market Cap

19.3B

Sector

Health Care

ML Signal

HOLD

Logo Cognex Corporation

CGNX

Cognex Corporation

HOLD

Current Price

$36.42

Market Cap

6.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXAS
CGNX
Founded
1995
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
19.3B
6.1B
IPO Year
N/A
1989

Fundamental Metrics

Financial Performance
Metric
EXAS
CGNX
Price
$101.91
$36.42
Analyst Decision
Buy
Buy
Analyst Count
20
11
Target Price
$77.94
$46.64
AVG Volume (30 Days)
4.9M
1.9M
Earning Date
02-18-2026
02-11-2026
Dividend Yield
N/A
0.93%
EPS Growth
N/A
27.63
EPS
N/A
0.65
Revenue
$3,082,033,000.00
$971,705,000.00
Revenue This Year
$19.40
$9.46
Revenue Next Year
$13.51
$7.09
P/E Ratio
N/A
$56.09
Revenue Growth
14.47
10.23
52 Week Low
$38.81
$22.67
52 Week High
$102.66
$49.76

Technical Indicators

Market Signals
Indicator
EXAS
CGNX
Relative Strength Index (RSI) 85.29 43.55
Support Level $101.45 $36.12
Resistance Level $102.00 $36.80
Average True Range (ATR) 0.39 1.08
MACD -1.26 0.16
Stochastic Oscillator 88.69 48.96

Price Performance

Historical Comparison
EXAS
CGNX

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About CGNX Cognex Corporation

Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the maximum proportion of its sales in the United States and Europe.

Share on Social Networks: